Q2 Investor Summit Virtual Live Wednesday June 24 Jun 23, 2026 03:40PM
Q2 Investor Summit Virtual Live Wednesday June 24 Jun 23, 2026 03:40PM
Oragenics signs letter of intent to license blood purification technology May 7, 2026 08:30AM
Sigyn Therapeutics explores NASDAQ merger, establishes clinical pathway Jan 15, 2026 11:01AM
Sigyn Therapeutics, Inc. to Present at the LD Micro Main Event XIX Oct 21, 2025 12:31PM


Oct 17, 2025 12:19PM Sigyn Therapeutics, Inc. to Present at the LD Micro Main Event XIX
Jul 1, 2025 10:27AM RETRANSMISSION: Goldman Small Cap Research Publishes New Research Report on Sigyn Therapeutics Inc.
Jul 1, 2025 08:55AM Goldman Small Cap Research Publishes New Research Report on Sigyn Therapeutics Inc.